Structure Therapeutics (GPCR) Other Operating Expenses (2025)

Structure Therapeutics (GPCR) posted quarterly Other Operating Expenses of -$110.2 million for Q4 2025.

Structure Therapeutics (GPCR) Other Operating Expenses (2025) Analysis & Trends

Structure Therapeutics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at -$110.2 million for Q4 2025.

In Q4 2025, Other Operating Expenses changed N/A year-over-year to -$110.2 million; the TTM figure through Mar 2026 stood at -$110.2 million (changed N/A YoY), while the FY2025 annual figure was -$110.2 million, changed N/A from the prior year.
Other Operating Expenses for Q4 2025 stood at -$110.2 million.
The five-year high for Other Operating Expenses was -$110.2 million in Q4 2025, with the low at -$110.2 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Structure Therapeutics	11.65 Bn	11.65 Bn	-

Download Data

Date	Value
Dec 31, 2025	-110.25 Mn